Holen Sie sich die Stockscreener-App
1.83
133.15%
1.072
Schlusskurs vom Vortag:
$0.758
Offen:
$1.92
24-Stunden-Volumen:
220.84M
Relative Volume:
57.45
Marktkapitalisierung:
$2.50M
Einnahmen:
$75,000
Nettoeinkommen (Verlust:
$-39.09M
KGV:
-0.00645
EPS:
-283.7191
Netto-Cashflow:
$-11.45M
1W Leistung:
+237.21%
1M Leistung:
+98.53%
6M Leistung:
-93.30%
1J Leistung:
+0.00%
1-Tages-Spanne:
$1.72
$2.25
1-Wochen-Bereich:
$0.4902
$2.25
52-Wochen-Spanne:
$0.4101
$166.50
Profusa Inc Stock (PFSA) Company Profile
Firmenname
Profusa Inc
Sektor
Branche
Telefon
212-494-9022
Adresse
207 WEST 25TH ST, 9TH FLOOR, NEW YORK
Compare PFSA vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PFSA
Profusa Inc
|
1.84 | 1.03M | 75,000 | -39.09M | -11.45M | -283.72 |
ABT
Abbott Laboratories
|
102.05 | 178.75B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
331.17 | 126.97B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.46 | 111.22B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.26 | 93.36B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.03 | 46.73B | 6.07B | 1.06B | 1.34B | 1.8063 |
Profusa Inc Aktie (PFSA) Neueste Nachrichten
Profusa shares surge after $30M PanOmics acquisition LOI signals pivot into molecular diagnostics - Quiver Quantitative
Profusa (PFSA) Stock Soars 173% on $30M PanOmics Diagnostics Acquisition - Blockonomi
Profusa (PFSA) Stock Rockets 173% After $30M Oncology Platform Deal - CoinCentral
Profusa’s Strategic Meeting Sparks Investment Talks - timothysykes.com
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Why Is Profusa Stock Soaring Monday?Profusa (NASDAQ:PFSA) - Benzinga
Why Did PFSA Stock Surge 80% Pre-Market Today? - Stocktwits
Profusa expands into multi-billion dollar precision diagnostics market with $30m letter of intent for a PanOmics platform - marketscreener.com
Profusa Amends Financing and Pursues PanOmics Acquisition - TipRanks
Profusa Expands Convertible Note Capacity to $12.22 Million, Issues $555,555 12% Note - TradingView
Profusa to acquire multi-omics platform, partners with Mayo Clinic By Investing.com - Investing.com India
Profusa Expands into Multi-Billion Dollar Precision Diagnostics Market with $30M Letter of Intent for a PanOmics Platform - The Manila Times
Profusa (Nasdaq: PFSA) signs $30M PanOmics diagnostics LOI - Stock Titan
Profusa Expands into Multi-Billion Dollar Precision - GlobeNewswire
PFSA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
NVACW SEC FilingsProfusa Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Profusa Delays Annual Report Amid Wider Losses - TipRanks
Profusa (NVACW) delays 2025 Form 10-K; $31.9M loss after merger - Stock Titan
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
PFSA Technical Analysis | Trend, Signals & Chart Patterns | PROFUSA INC (NASDAQ:PFSA) - ChartMill
PFSA Should I Buy - Intellectia AI
Profusa Incenters amendment to promissory note with Northview Sponsor I LLC on March 20, 2026SEC filing - marketscreener.com
Profusa Extends Promissory Note Maturity, Enhancing Liquidity - TipRanks
Profusa (NASDAQ: PFSA) pushes promissory note maturity to December 2026 - Stock Titan
Profusa outlines revenue plan, targets EU commercial launch of Lumee in early Q2 2026 - MSN
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Profusa Implodes on Black Swan Volatility — 24.7% Plunge as Bets Turn to Panic - Bitget
Profusa (PFSA) Stock Forecast and Price Target 2026 - MarketBeat
NVACW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Profusa to liquidate Bitcoin holdings and faces Nasdaq delisting process By Investing.com - Investing.com Canada
According to the latest filing submitted to the U.S. Securities and Exchange Commission (SEC), biosensor technology company Profusa Inc has officially decided to terminate its Bitcoin treasury reserve strategy. - Bitget
Profusa terminates Bitcoin Treasury Reserve Strategy and to liquidate Bitcoin holdings - marketscreener.com
Profusa to liquidate Bitcoin holdings and faces Nasdaq delisting process - Investing.com
Profusa to End Account Control Agreement With Ascent Partners as It Exits Bitcoin Strategy - TradingView
Profusa (NASDAQ: NVACW) warned on delisting as it ends Bitcoin reserve plan - Stock Titan
Profusa (PFSA) & Its Peers Financial Contrast - Defense World
PFSA Earnings History & Surprises | EPS & Revenue Results | PROFUSA INC (NASDAQ:PFSA) - ChartMill
PFSA SEC FilingsProfusa Inc 10-K, 10-Q, 8-K Forms - Stock Titan
PFSA Financials: Income Statement, Balance Sheet & Cash Flow | Profusa Inc - Stock Titan
Profusa, Mayo Clinic to Advance Clinical Applications of Oxygen Monitoring Technologies - Medical Product Outsourcing
[POS AM] Profusa, Inc. SEC Filing - Stock Titan
Head-To-Head Comparison: Profusa (PFSA) versus Its Competitors - Defense World
PFSA Technical Analysis & Stock Price Forecast - Intellectia AI
Profusa cancels $15M public offering, plans smaller fundraise By Investing.com - Investing.com Canada
Profusa cancels $15M public offering, plans smaller fundraise - Investing.com South Africa
Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering - GlobeNewswire
Biosensor technology company Profusa Inc announced that revenue from its Lumee oxygen monitoring product in the European market is expected to receive substantial support starting from the second quarter of 2026. - Bitget
Profusa’s Market Moves as Revenue Reports Spark Uncertainty - StocksToTrade
Profusa Inc. Stock Declines Amid Financial Struggles and Market Uncertainty - timothysykes.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Finanzdaten der Profusa Inc-Aktie (PFSA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.07%
0.30%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):